Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rajkumar

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Leukemia|December 30, 2015
Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumorsA K Mitra, U K Mukherjee, T Harding, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Archives of Microbiology|January 25, 2025
Production of biologically active recombinant salmon calcitonin in Escherichia coli and fish cell lineA Nafeez Ahmed, S Abdul Majeed, G Taju, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Leukemia|December 30, 2015
Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumorsA K Mitra, U K Mukherjee, T Harding, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Archives of Microbiology|January 25, 2025
Production of biologically active recombinant salmon calcitonin in Escherichia coli and fish cell lineA Nafeez Ahmed, S Abdul Majeed, G Taju, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
American Journal of Hematology|January 5, 2002
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantationS V Rajkumar, R Fonseca, A Dispenzieri, et al.
Leukemia|February 26, 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myelomaK Detweiler Short, S V Rajkumar, D Larson, et al.
Pageof 17